Joseph Bedford appointed corporate vice president of global strategic marketing at Huntingdon/Harlan

27 May 2015

Huntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president of global strategic marketing.

This is a newly-created position that the companies see as strengthening their international strategic marketing function across its contract research and research models business units. Dr Bedford joins the company from Taconic Biosciences where he was vice president of global marketing.

Adrian Hardy, chief operating officer at Huntingdon Life Sciences and Harlan Laboratories, said: “We are delighted that Joe has joined the organization. This is an especially important time for us as we continue to develop the combined, integrated brand of the two companies. Joe’s strong expertise in strategic marketing across both the CRS and RMS CRO space will prove to be a great asset to the organization, and he brings an experienced new voice to the team.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK